A new Stryker hip replacement lawsuit charges that the plaintiff, Tracy Sponer of Arkansas, experienced serious complications from the company’s Rejuvenate hip implant system. Sponer filed her lawsuit on November 7, 2012 in the U.S. District Court, Eastern District of Arkansas.
Sponer’s complaint states that on September 6, 2011, she was surgically implanted with the Rejuvenate hip system at the Arkansas Surgical Hospital in Little Rock, Arkansas. But she began to suffer complications that were so severe that only 12 days after receiving the implant, she had to undergo painful Stryker hip revision surgery on September 18, 2012 to have it removed and replaced.
The lawsuit charges that Stryker failed to conduct investigations and analyses of implant failures and failed to report Rejuvenate complications in a timely manner. Her complaint brings counts of failure to warn, defective design and manufacture, negligence, and breach of warranties.
Introduced by Stryker in February 2009, the Rejuvenate Modular Primary Hip System was promoted as offering greater stability than earlier implants and giving surgeons more options and flexibility when fitting it to a patient’s body, because the Rejuvenate had a two-piece design, with a chrome cobalt modular neck inserted into a titanium femoral stem.
According to Sponer’s complaint, Stryker also claimed in promotional materials that the proprietary titanium alloy used in the Rejuvenate was stronger and less rigid than other titanium alloys, and that this alloy had been tested and had proven to resist corrosion and fretting. But despite these claims, the company ultimately admitted in July 2012 that the Rejuvenate was in fact prone to corrosion and fretting after being implanted in patients’ bodies, and a Stryker Rejuvenate hip implant recall was issued that month.
Three months prior to the U.S. recall, Stryker had issued an urgent safety alert to U.S. surgeons and hospitals in April 2012, warning them of reports of Rejuvenate implant failures caused by heavy metal contamination. At that time, Stryker recalled the Rejuvenate in Canada, but left it on the market in the U.S. But three months later, in July 2012, the implant was recalled in the U.S as well.
After the Rejuvenate was recalled, many patients who had experienced complications and implant failures from the device took the step of consulting a Stryker hip recall lawyer and filing lawsuits against the company.